Wilson Catapani was graduated in Medicine from the Federal University of São Paulo, in 1977, with a two year subsequent Residency in Gastroenterology at the same institution. Also at the Federal University of Sao Paulo, he got my Master and later, a Doctorate degree in Gastroenterology. He had training as a research fellow at the Western General Hospital in Edinburgh, Scotland, under the superv...
Wilson Catapani was graduated in Medicine from the Federal University of São Paulo, in 1977, with a two year subsequent Residency in Gastroenterology at the same institution. Also at the Federal University of Sao Paulo, he got my Master and later, a Doctorate degree in Gastroenterology. He had training as a research fellow at the Western General Hospital in Edinburgh, Scotland, under the supervision of Professor Anne Ferguson, during 1990. Later on, he moved to the ABC Foundation School of Medicine, in Santo André, near Sao Paulo, where he is currently Full Professor of the Gastroenterology Section. He is also an American College of Gastroenterology fellow.
has completed his MD at the age of 25 years from Tehran University and
gastroenterology fellowship from Ahvaz jundishapur University of Medical
sciences. He is currently Assistant professor of Gastroenterology and
hepatology, member of the Research Center for Infectious Diseases of Digestive
System, WEO star group and director of Celiac Society in Khuzestan province, a
premier health service organization. He has published more than 50 papers in
reputed journals and has been serving as an editorial board member of
gastroenterology and hepatology open access journal.
Field of Hepatology, Small bowel disorders
specially celiac disease
Abdul-Wahed N. Meshikheswas born in Al-Awamiyah, Qatif, Saudi Arabia in 1958. He did the 'A' level certificate of higher education in Worthing College of Technology, West Sussex, England in 1977. He qualified from the Royal College of Surgeons in Ireland in June 1984 and did his internship year in Scotland. He did his postgraduate surgical training in Manchester, England and obtained the fellowship of the Royal College of Surgeons in 1989. He also did one year fellowship in liver transplantation at Queen Elizabeth Hospital, Birmingham, UK in 1993.
He worked as consultant surgeon and chairman of Surgery Department at Dammam Central hospital from 1991 till May 2005, when he joined King Fahad Specialist Hospital, Dammam as the chairman of department of surgery to establish the department. He chaired the department till 2011. He is currently the head of general and minimally invasive surgery section. His main clinical interest is gastrointestinal surgery, surgical gastroenterology and surgical training and education. His research interest concentrates on surgery in sickle cell disease and hand assisted laparoscopic surgery.
Meshikhes have authored many peer-reviewed articles which were published in many international journals. He is also a member of the editorial board of some international journals such as World Journal of Gastroenterology, World Journal of Surgical Procedures, ISN Minimally Invasive Surgery, Journal of Gastroenterology and Hepatology Research and Journal of Tumour.
Gastrointestinal surgery, surgical gastroenterology, surgery in sickle cell disease and hand assisted laparoscopic surgery
Georgios Tsoulfas received his medical degree from Brown University School of Medicine and completed his general surgery residency at the University of Iowa Hospitals and Clinics, as well as a transplant research fellowship at the Starzl Transplant Institute at the University of Pittsburgh. He then completed a two-year transplantation surgery fellowship at the Massachusetts General Hospital, Harvard Medical School and then joined the Division of Solid Organ Transplantation and Hepatobiliary Surgery at the University of Rochester Medical Center as an Assistant Professor of Surgery. He has currently moved back to Greece, where he is an Assistant Professor of Surgery at the Aristoteleion University of Thessaloniki. He has published over 70 papers in peer-reviewed Journals and in PubMed, as well as 17 book chapters. He is a reviewer for 15 International Journal and on the Editorial Board of several others.
His main area of interest include primary and metastatic hepatic malignancies and their multimodal management.
Hepatobiliary sugery, Abdominal organ transplantation, Surgical education, Surgical oncology, Hepatocellular cancer liver metastatic disease, Cholangiocarcinoma
Sorin T Barbu
Iuliu Hatieganu University of Medicine and Pharmacy
Sorin T Barbu received his PhD in medical sciences with the thesis “Surgery for chronic pancreatitis”, and he developed his surgical skills in several European centers (Paris, Hamburg, and Bergen). Dr. Barbu had an academictraining stage at the University Paris VI, and currently he isa professor of surgery at the “IuliuHatieganu” University of Medicine and Pharmacy in Cluj, working as a primary surgeon in the 4th Surgery Department of the University. He is the President of the Romanian Pancreatic Club, vice-president of the Romanian Society of Coloproctology, Councilor in the European Federation of the International Society for Digestive Surgery (EFISDS) and member in the general assembly of United European Gastroenterology (UEG) as EFISDS representative.
Dr. Barbu research focuses on pancreatitis and periampullary tumors. He was an editorial representative in Pancreatology editorial board (2006 – 2011) and now he is the Romania representative in the Management Committee of the COST action BM1204 “EU Pancreas”. Dr. Barbu was involved in several guidelines for acute pancreatitis (International Association of Pancreatology 2002, Romanian guidelines 2005), criteria for alcoholic pancreatitis 2006, and guidelines for inherited diseases of the pancreas 2012. As a surgeon, he’s interested in oncologic, laparoscopic and HPB surgery. As a teacher, he organized several international postgraduate surgical courses in collaboration with EFISDS, European Pancreatic Club (EPC), and European Digestive Surgery (EDS), most of them with the UEG support.
Pancreatology, oncologic surgery (complete mesocolic excision) and minimally invasive techniques. Specific research topics include: influence of necrosis status on the outcome of acute pancreatitis, factors influencing necrosis liquetaction, development of pancreatic cancer on chronic pancreatitis, precursor lesions of pancreatic cancer and their evolution with implications for surgery.
David E Rivadeneira, currently serves as the Vice Chair, Surgical Strategic Initiatives for North Shore-LIJ Health System and Director of Surgical Services and Colorectal Surgery at Huntington Hospital. He also holds an academic appointment asProfessor of Surgery at Hofstra University School of Medicine.
He received his medical degree with honors from Howard University College of Medicine, Washington, DC and an MBA from Adelphi University, Garden City, NY. His residency in surgery was completed at New York Presbyterian Hospital - Cornell Medical Center, Department of Surgery, and Memorial Sloan Kettering Cancer Center in New York, where he served as Chief Resident. In addition he spent two years as a NIH funded research oncology fellow at Cornell University School of Medicine. Following his residency, he completed a fellowship at the Lahey Clinic Medical Center, Department of Colon and Rectal Surgery in Burlington, MA. Prior to his current appointment, he served as Associate Professor of Surgery at State University at Stony Brook School of Medicine in Stony Brook, NY and as Director of Colorectal Surgery at St. Catherine Hospital in Smithtown, NY.
Recognized as a leader in colon & rectal surgery and for his advanced skills in minimally invasive surgery, he has a major interest in laparoscopic, and other minimally invasive procedures including advanced robotic procedures for the treatment of colon and rectal diseases, including cancer. He has published extensively with more than 60 peer reviewed articles and book chapters. He has served on numerous committees for the American Society of Colon & rectal Surgeons, including Quality Assessment and Safety Committee, Program, Clinical Practice Guidelines Committee, and chair of the Awards committee. With an extensive experience teaching laparoscopic colon surgery to hundreds of surgeons throughout the United States and abroad, he has served as Director of numerous Laparoscopic educational courses for industry, academic institutions and for the American College of Surgeons. He has received numerous honors and awards including Castle & Conollys Top Doctors, New Yorker magazine Best Doctors, Best Doctors in America, New York’s Top Doctors, Castle Connolly’s Top Doctors, America’s Top Surgeons, New York Super doctors, Who’s Who in America, Who’s Who in the World, Alpha Omega Alpha Honor Medical Society, and American Association of Cancer Research Scholar Award.
Investigate new cancer markers in solid tumors, Investigate level of telomerase activity in peritoneal cancer cells, cancer-induced cellular dysfunction , Determined macrophage and hepatocyte apoptosis in surgical nutritional states, metabolism of cyclosporine
NikolaosPyrsopoulos, M.D., Ph.D., M.B.A., F.A.C.P., AGAF., is the Chief of Gastroenterology and Hepatology and Medical Director of Liver Transplantation at Rutgers University NJSM. .
He completed his medical degrees (MD and PhD) at the University of Athens in Greece, followed by residency and fellowships at Sismanogleio General Hospital in Athens and the University of Miami School of Medicine. Pyrsopoulos is board certified in the areas of Internal Medicine, Gastroenterology and Transplant Hepatology. He received his M.B.A. from the University of Miami School of Busines.He formerly served as an Assistant Professor of Medicine and Medical Director of Liver Transplantation at Jackson Memorial Hospital, University of Miami and Broward General Medical Center in Fort Lauderdale. He was an Associate Professor of Medicine at The University of Central Florida College of Medicine, Chief of Hepatology, Medical Director of Liver Transplantation and the Hepatology Fellowship Program Director at Florida Hospital where he was one of the founding members of the liver transplant program and the Hepatology Fellowship in Central Florida. His publications include various scientific journals, including the Journal of Gastroenterology, Hepatology and Transplantation and one of the authors of the unique in the field of abdominal transplantation book: Intestinal and multivisceral transplantation. Dr. Pyrsopoulos is also a Fellow of The American College of Physicians, and the American Gastroenterological Association. He is a member of various medical associations such as the American Association of the Study of Liver diseases, The European Association of the study of the Liver, the American Society of Gastrointestinal Endoscopy and the American Society of Transplantation, among others. He has served in numerous national and institutional committees. He has participated in multiple international and national research projects. His vision is excellence in patient care, providing outstanding education to the fellows, residents and students and promoting the science of medicine by conducting research.
In his new position, Dr. Stephen Cohen is leading the way
for improved surgical care in Southern West Virginia. He is starting a new
surgical program while utilizing his general surgery, endoscopy, and leadership
skills as Director of Acute Care Surgery at Greenbrier Valley Medical
He was the first Board certified colon and rectal surgeon
for the southern crescent area in Atlanta, Georgia. Many of his patients
traveled long distances to receive his high quality care, due to his unique
ability to put patients and family at ease during difficult and often stressful
times. He is an innovator, pioneer, and pacesetter of emerging, developing, and
innovative colorectal techniques. Painless hemorrhoid treatments,
state-of-the-art incontinence procedures, and new paradigms in postoperative
care are several of the interests that Dr. Cohen's patients receive in his
quest to identify the newest and most advanced treatments available. He is
active in teaching, educating, and collaborating with physicians both
domestically and internationally, in which his passion is advocating for
advances in colorectal diagnosis and treatment, promoting quality access, and
maintaining affordability in the current healthcare debate. In addition, Dr.
Cohen recently earned his MBA degree and is a two-time Ironman triathlon
finisher. Because of his current life-style change, He is passionate about
educating and teaching, in addition to, promoting nutrition as a mainstay for a
healthy way of living.
Dr. Cohen has partnered with medical industry for the past
25 years to educate, teach, and promote innovative technology that adds value
for patients, physicians, and the institution. Furthermore, as a leader in the
field of colon and rectal surgery, He prides himself on keeping abreast about
evidence-based medicine, and is a consultant for many medical-legal cases that
require his particular skills for a fair and just review.
Smith was born in Sydney, Australia. He came to Minnesota where he established a large hepatology practice in the Twin Cities. He has been active in clinical research and teaching fellows and residents at the University of Minnesota and Abbott Northwestern Hospital in Minneapolis for over 20 years. He has been part of many protocols, including many of the registration trials for drugs used in the treatment of viral hepatitis. He is the principal investigator at the University of Minnesota for a large Hepatitis B multi-site study, funded by the NIH. He has a research interest in hepatocellular carcinoma and has established a multi disciplinary liver cancer group at Abbott Northwestern Hospital
Xintao Wang received his Ph. D. in biochemistry from Rome University “La Sapienza” in Italy. He worked to study the structure and functions of copper proteins in University of Quebec at Montreal in Canada for three years. He joined Albert Einstein College of Medicine in 1998 and focused on the study of potassium channel regulation by PKC phosphorylation. Currently, he works in the Marion Bessin Liver Research Center of Albert Einstein College of Medicine to study the molecular mechanisms for the motility regulation of endocytic vesicles isolated from hypatocytes. Sodium taurocholate co-transporting polypeptide (NTCP/ntcp) is a bile acid (BA) transporter predominantly expressed on the basolateral (sinusoidal) plasma membrane of hepatocytes. Ntcp transports BA from the portal blood into hepatocytes in a sodium-dependent fashion. Ntcp transport activity can be regulated by insertion of ntcp into and retrieval from the plasma membrane via vesicles. Previously, our group showed that ntcp traffics in vesicles along microtubules using kinesin-1 and dynein, plus and minus end directed motors respectively, in a process requiring PKC activity. The role of PKC and its target of phosphorylation are unknown
Identification and characterization of the PKC target on ntcp-containing endocytic vesicles.
Natalia A Osna graduated with MD/PhD degrees from Riga Medical University, Riga, Latvia. After graduation, she have been working for many years at Center of Hepatology, Department of Immunology, Latvian Medical Academy, Riga, Latvia. Then she got several fellowships at London (King’s College), UK and Copenhagen (Statens Institute), Denmark and moved to US. Currently, she is an Assistant Professor in Division of Gastroenterology, University of Nebraska Medical Center, Omaha, Nebraska, US. The major fields of my interests are hepatitis C and B infections, alcoholic liver diseases, innate immunity, proteasome degradation, methylation reactions, experimental nanomedical approaches to HCV and alcohol hepatitis treatments. She have about 60 publications in peer-reviewed journals, many talks at International Meetings and collaborations.
Alcoholic Liver Disease
Innate immunity/interferon signaling
Role of methylation in regulation of interferon signaling
Uwe Blecker after receiving the B.S. in medical sciences in 1986, he then earned the M.D. magna cum laude from Free University of Brussels, Belgium in 1990. He then completed a pediatric residency from 1990-93 at Academic Children’s Hospital in Brussels. From 1993-94, he was a fellow in pediatric gastroenterology and nutrition at Hahnemann University Hospital in Philadelphia, Penn. In 1994, he continued his fellowship in pediatric gastroenterology, hepatology and nutrition at Wyler Children’s Hospital at the University of Chicago. In 1994, he returned to Academic Children’s Hospital to complete his fellowship in pediatric gastroenterology and nutrition.
He served as director of the Sleep Lab and Pediatric Gastroenterology Admission Unit at the Free University of Brussels from 1995-96 before joining Louisiana State University School of Medicine as associate professor of pediatrics and medical director of the LSU Medical Center Pediatric Weight Management Program. In 1998, he joined the faculty at Thomas Jefferson University as associate professor of pediatrics and director of Nutrition Support Services at Alfred I. DuPont Hospital for Children in Philadelphia, Penn. In 2000, he became professor of pediatrics and chief of the Division of Pediatric Gastroenterology and Nutrition at The University of Arizona Health Sciences Center in Tucson. In 2001, he joined the staff of St. Christopher’s Hospital for Children and Drexel University in Philadelphia as professor of pediatrics and chief of the Division of Gastroenterology, Hepatology and Nutrition. He returned to Tucson in 2002 as director of the Pediatrics and Gastroenterology program at Tucson Medical Center and director of Pediatric Gastroenterology, P.C. He became professor of pediatrics and chief of the Division of Pediatric Gastroenterology and Nutrition at West Virginia University Health Sciences Center in 2008. Prior to joining the Medical Center, he was a pediatric gastroenterologist at Centre Hospitalier Emile Mayrisch in Luxembourg from 2009 to 2014.
He is board-certified in pediatrics and pediatric gastroenterology and nutrition.
He has served as co-principal investigator or principal investigator for numerous studies and is the author of more than 100 articles in peer-reviewed publications, four books, six book chapters and nearly 300 communications at national and international meetings.
Nilesh Mehta was born and brought up in Northern India where even at a young age; he was highly influenced by multiple physicians in his family. He has always been interested and active in several sports, namely table tennis. He completed his schooling in Pune where he actually won the district table tennis championship. During his time in Pune, He was able to distinguish himself by competing and winning the prestigious National Talent Search Examination [NTSE] and he ranked in the top 0.5% of 18,000 candidates. After completing his medical education at Mahatma Gandhi Memorial Medical College, Indore, He was accepted in a training program at Ahmadabad. During his Ophthalmology residency he assisted the editor of the National Journal of Ophthalmology. In 2001, he moved to Columbia University residency program at Harlem Hospital Center. During his third year of Internal Medicine residency, He authored the online article – “Drug-induced Hepatotoxicity” in E-Medicine, now taken over by Meds cape. Subsequently, Nilesh spent two years in Hepatology research at SUNY Upstate Medical University in Syracuse, NY. Under the guidance of Dr. Szyjkowski and Dr. Murthy, He presented research at national and international conferences. In June of 2009, He completed his fellowship training in Gastroenterology and Hepatology at SUNY Upstate Medical University. Nilesh is also a guest lecturer for SUNY Stony Brook University Health Sciences Center and in 2014; he began serving as a Physician Assistant Preceptor. He has several publications with his most prominent work published in Gastrointestinal Endoscopy - Postpolypectomy Bleeding in Patients Undergoing Colonoscopy on Uninterrupted Clopidogrel Therapy. He now has a private practice with multiple locations in the Long Island and Queens area of New York and he is also actively involved in clinical research trials.
Acinar cell events in acute pancreatitis, protein kinase C (PKC)-dependent and protein kinase D (PKD)-dependent pathways in the pathogenesis of acute pancreatitis,intracellular calcium signaling pathways.
Nelson Carrillo is Professor in Gastroenterology in four Hospitals in Caracas Venezuela South America. He obtained his MD from the Venezuelan Central University (UCV) in 1965. He taught Gastroenterology in the Venezuelan Central University (UCV) and was Chairman of the Postgraduate Gastroenterology Service in the Venezuelan Institute of Social Security (IVSS). He is Co--‐Editor in GEN ( Journal of the Venezuelan Society of Gastroenterology) in the images Section. His current activity involves the teaching of images in Gastroenterology for Postgraduates Since 2012. He has given 56 Cases discussions in four Hospitals of Caracas Venezuela.
Images in Gastroenterology-Ultrasonography in Gastroenterology and Hepatology-Gastrointestinal Radiology.
Robert J Richards received his medical degree (MD) from the New York Medical College of Valhalla, NY. He completed a Fellowship in Gastroenterology at the Yale University affiliated Program of Bridgeport Hospital. He earned a Masters Degree in Statistics and Clinical Research from the University of Michigan, Ann Arbor, and a Master’s of Science Degree in Health Policy and Management at Harvard University in Boston. He is Associate Professor of Clinical Medicine at Stony Brook University, Stony Brook, NY. His area of interest and expertise is Inflammatory Bowel Disease. He has conducted a number clinical trials aimed at investigating new treatments (including mesenchymal stem cell therapy) for Crohn's disease. He has been the recipient of several prestigious NIH awards and currently is co-investigator for an NIH funded project, which is assessing the accuracy of virtual colonoscopy. He has published more than 35 articles in peer-reviewed medical journals and has given numerous local and national lectures on inflammatory bowel disorders, Crohn's and ulcerative colitis. He is board certified in Gastroenterology/Hepatology.
Wei Wang, now works as an attending doctor in Department of Medical Oncology, Anhui Provincial Hospital, PR.China. So far, he has published more than 60 papers; during which, 24 were SCI papers published by the journals of Clin Chim Acta, Int J Clin Exp Pathol,Eur J Surg Oncol，Dig Dis Sci，Med Oncol and Cell Biol Int, etc.In recent years, he has implemented 2 projects from National Natural Science Foundation and Anhui Provincial Education Department of China and participated in more than 5 projects from National Natural Science Foundation of China. He serves as a reviewer of International Immunopharmacology, Journal of Thoracic Disease, Cancer & Clinical Research Journal, Rare Tumor, etc. All SCI papers and research projects are closely associated with the clinical and basic research of tumors.
Clinical and basic research on tumor angiogenesis and anti-angiogenic target therapy, especially for liver cancer.
University of Texas Health Science Center San Antonio
Fernando Membreno, MD is a Transplant Hepatologist with 10 yrs of experience in patient care. His career as a hepatologist brought him to San Antonio in 2006, since then his practice of medicine has been devoted to the care of patients with all types of liver diseases. His academic interests have focused in research of new therapies for Hepatitis C and liver cancer.
He graduated from medical school at the Autonomous School of Medicine in San Jose, Costa Rica (1995) and did his internal medicine residency at the Staten Island University Hospital in Staten Island, New York. Due to his interest in liver diseases he completed a Gastroenterology/Hepatology Fellowship and a Master of Science in Clinical Research at the University of Texas Medical Branch in Galveston, Texas. He then pursued further experiences in liver transplantation at the University of Colorado/VA Medical Center in Denver, Colorado. He is board certified in Internal Medicine, Gastroenterology/Hepatology and Liver Transplantation (CAQ- Certificate of Added Qualification).In 2006, he became the medical Director of the Liver Transplantation program at The Methodist Specialty and Transplant Hospital in San Antonio. After working 5 years exclusively as a Transplant Hepatologist, He, joined the The Texas Liver Institute where he worked in clinical Hepatology. He has been a co-investigator in many clinical trials using the newest antiviral medications for the treatment of Hepatitis C and in various fields of hepatology. Currently He has become an associate faculty professor at the University of Texas Health Sciences Center and The Texas Liver Institute to bring the highest level of care to all patients who suffer from any type of liver disease in San Antonio and surrounding areas.
Hepatitis C new therapies, liver cancer and fatty liver (NASH)
Leila Gobejishvili received PhD degree in Physiology in 1995. The focus of her research is the role of cAMP in the modulation of inflammation and organ injury. cAMP a critical second messenger regulating myriad of cellular functions and its levels are tightly controlledby phosphodiesterases (PDEs) to ensure adequate responses of the cell. Among a large family of PDEs, PDE4 is ubiquitous cAMP-specific family with four subfamilies and more than 20 isoforms. Her major interest is the mechanisms of alcoholic and non-alcoholic liver injury. Her earlier work examined the underlying mechanisms of alcohol mediated priming of monocytes/macrophages to produce higher levels of pro-inflammatory cytokine TNF. She demonstrated that chronic alcohol results in a significant depletion of intracellular cAMP levels caused by increased expression and activity of PDE4. These findings strongly supported the pathogenic role of PDE4B in the ethanol-mediated priming of monocytes/macrophages and increased LPS-inducible TNF production and the subsequent development of ALD. Later she demonstrated that the anti-inflammatory mechanism of S-Adenosylmethionine can be attributed primarily to its ability to inhibit LPS-induced PDE4B2 expression, increase cellular cAMP levels and modulate PKA and NFκB activity.More recently, She demonstrated that PDE4 enzymes could also contribute to the development of hepatic fibrosis. Despite the major advances made in understanding the underlying mechanisms of pathogenesis of ALD, but there is still no FDA approved therapy to date to treat ALD. Her goal is to better understand mechanisms of liver disease leading to new therapies.
Lee graduated Kyungpook National University medical school in Daegu, Korea in 1998. He received his M.S. in 1994 and his Ph.D. in 2000 from Kyungpook National Univerisity, Daegu, Korea.
He completed medical residency in 1996 and fellowship for gastroenterology in 1997 in Kyungpook National University Hospital. He had undergone research fellowship in Hemodynamic Laboratoy, Department of Internal Medicine, Yale University School of Medicine from 2003 to 2004.
He have worked in Gastroentrologic Department, Catholic University School of Medicine from 1997. He also have been tenure track as professor from 2009. He have had licensure and certification of Gastroentrology from 1998 and Critical Care Medicine from 2009 in Korea. He participated in member of committee for development of KASL (Korea Associate for Study of Liver) guideline for Clinical Practice Guideline for Liver Cirrhosis in 2011 and Alcoholic Disease in 2013. His main interest for study are Portal hypertension and complication of liver cirrhosis. He also be interested in viral hepatitis.
Portal hypertension, Viral hepatitis, Comprehensive and Integrative Medicine.
Hui Yang received his B.S. from the School of Gannan Medical College in JiangXi in 2003. He received his M.S. in 2006 and his Ph.D. in 2010 from Guangzhou Medical University in Guanghou China. In 2007, he joined Yu-Jui Yvonne Wan’s lab in University of Kansas Medical Center to study molecular biology of the liver cancer. After two years, he worked as postdoctoral fellow in Wan’s lab. In 2010, he was recruited by the Department of Gastroenterology of the Second Affiliated Hospital in Guangzhou Medical University. His studies focus on the molecular mechanisms of HDACi antitumor effects and the pathophysiology of the liver. The goal is to identify potential therapeutic targets in the prevention and treatment of liver disease.
Mechanism underlying the development of metabolic syndromes, Fatty liver, Fibrosis, Cirrhosis and Liver cancer.
Tomica Milosavljevicis a full-time Professor of Medicine at the Medical Faculty, University of Belgrade, at the Gastroenterology and Hepatology Clinic- Clinical Center of Serbia. He graduated from Medical Faculty, University of Belgrade, Serbia in 1979. He had his specialty training at the Clinical Center of Serbia, and obtained PhD degree (1988) at the University of Belgrade. He is president of Serbian Association of Gastroenterologists (2009-2013) and he is a past president of Yugoslavian Coloproctology Society (2003-2007) and a past president of Yugoslavian Association for Digestive Endoscopy (1996-2000). He was serving as a Minister of health of Serbia 2002-2003, 2004-2006 and 2007-2011. He was member of Executive Board of WHO 2009-2012, and a member of Standing Committee of WHO for Europe 2005-2008, and he was a president of 57th Session of RC WHO Euro, in 2007.
He is a member of the Council of EAGEN (European Association for Gastroenterology, Endoscopy and Nutrition) since 2008, and he is serving as a member of UEG General Assembly ( 2012-15), representing EAGEN.
He also serves as an editor of Archives of Gastroenterohepatology, and an international editorial board member of Hepatogastroenterology. He was authored more than 300 publications; he has been a speaker, chairman and organizer at numerous national and also international symposia and congresses.
Helicobacter pyloriinfection and related diseases;
chronic inflammation and carcinogenesis;
Inflammatory bowel diseases, pancreatic diseases, diagnostic and therapeutic endoscopy.
Somchai Amornyotin graduated at the Faculty of Medicine Siriraj Hospital, Mahidol University in 1989. He became the staff of the Department of Anesthesiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand in 1996. Until 2004 he became the associate professor of the Department of Anesthesiology, Faculty of Medicine Siriraj Hospital, Mahidol University. From 2005 until 2009 he was the chief of Anesthesiology Division of Siriraj GI Endoscopy Center, Faculty of Medicine Siriraj Hospital, Mahidol University. His paper was published in Thailand in 1999.
He has practiced anesthesia for gastrointestinal endoscopy since 2002. He was the committee of Siriraj GI Endoscopy Center, Faculty of Medicine Siriraj Hospital in 2005. More than 50 of his articles have been published in Thai and international medical journals. Dr. Amornyotin is a member of the Royal College of Anesthesiologists of Thailand and many scientific societies. He is the reviewer and editor of many international journals
Anesthesia for gastrointestinal endoscopy
Total intravenous sedation (TIVA)
Target controlled infusion (TCI)
Sedation for pediatric patients
Anesthesia outside the operating room
Acute postoperative pain management
Walid Yousef Farah is currently a Senior Consultant Internist & Gastroenterologist & Hepatologist at Royal Commission Hospital in KSA. He received his MD degree from Aleppo University in Syria 1982, he is Board Certified in Internal Medicine, Gastroenterology and Hepatology in the years of 1992 & 2004. He worked at Royal Medical Services and Jordan University and Ministry of Health in Jordan and founded the Gastroenterology Unit at Prince Hamzah Hospital in Jordan. He is a member of various Medical Associations and published his articles in various national & international journals.
Non Alcoholic Steatohepatitis, Acid related disorders
Koutoubi is a Consultant Gastroenterologist and Hepatologist at Tawam Hospital in affiliation with John Hopkins Medicine International.
He joined Tawam Hospital in 2005 as Consultant Gastroenterologist and Hepotologist. He treated a large number of patients with hepatitis B and hepatitis C during his presence at Saint Louis University (Saint Louis, Missouri, USA), as well as in Tawam Hospital since 2005 (Al-Ain, UAE).
He did his Internal Medicine Residency training at Wright State University in Dayton, Ohio (USA), and he is American Board Certified in Internal Medicine (since 1998). Also he did his Gastroenterology and Hepatology Fellowship training at Saint Louis University in Saint Louis, Missouri (USA) and he is American Board Certified in Gastroenterology (since 2000).
He presented the hepatitis C and hepatitis B treatment experience at Tawam Hospital on many occasions during the national gastroenterology meetings in UAE, and he presented many abstracts regarding hepatitis B and Hepatitis C treatment in many national and international meetings.
All aspects of gastroenterology, Hepatology and endoscopy with special interest in the field of Hepatology.
SoetjiningsihBudiarsa, Professor in Pediatrics in the Department of Childhealth, School of Medicine, Udayana University, Denpasar, Bali, Indonesia. Graduated from Airlangga University Surabayain 1970 as General Practitioner, in 1981 as Pediatrician. Lactation Specialist Training Program, San Diego (1984), International Board Certified Lactation Consultant (2001, 2006).Pediatric Consultant for Growth & Development and Social Pediatrics since 1992. As an editor of many Indonesian medical books and Indonesian medical journals. As a writer of many medical books. Award from Indonesian Pediatrics Association on her effort to improve pediatrics training in Indonesia (2008).
Growth & development, community medicine, nutrition, breast feeding, gastroenterology.
Doctor Degree in Biotechnology in the area of Cancer Functional Proteomics(GD/CNPQ grant PhD thesis was developed at Surgery Department (Liver Transplantation, University Hospital HUWC/UFC) under supervision of Dr. OdoricoMoraes (M.D.) and Dr. Huygens Garcia (M.D.) and the experimental work wasperformed at University of Siena (UNISI) Italy, under supervision of Dr. Luca Bini(PDEE/Capes grant). Nowadays, work with Translational Medicine, morespecifically in serum biomarkers on HCC patients; molecular events of tumor microenvironment (cirrhosis) and the progression of Hepatocellular carcinoma (HCC) and transplantation biomarkers. Another areas: Hepatology, Cancer Biology Functional Proteomics, Interactomic (signaling pathways), pharmaceutical bioprospection. Develops a Pos-Doc experimental work (PDJ/CNPq grant) within the area of serum biomarkers in HCC, at University Hospital (HUWC/UFC – Liver Transplantation team).
Translational Medicine, Molecular Pathology, Hepatology/Liver Disorders, Oncology and
The North West London Hospitals NHS Trust
Ayesha Akbar joined the St Mark's consultant physician staff in 2010. Her clinical interests include general gastroenterology with a focus in inflammatory bowel disease. She also has an interest in abdominal pain and irritable bowel syndrome, especially in the overlap cases with inflammatory bowel disease, and sits on the British Society of Gastroenterology Neurogastroenterology committee. She is involved in service development including setting up a community gastroenterology service with the local PCT and has an interest in patient care and satisfaction. Ayesha is actively involved in education, teaching and research. She also holds several management roles, including the chair of her local LNC.
She undertook her specialist training in general medicine and gastroenterology in London, and has gained valuable experience from leading institutions including Hammersmith Hospital, Royal London Hospital, UCH and St James's University Hospital
Her research work at Imperial College London gained her a PhD entitled "Molecular mechanisms of visceral hypersensitivity in the colon." She has published her research in peer reviewed journals and presented her work at national and international meetings.
She studied medicine at the University of Manchester and was awarded an Honors degree. She has an outstanding academic record graduating top of her class and gaining several distinctions and honors along with prestigious prizes.
General gastroenterology with a focus in inflammatory bowel disease; abdominal pain and irritable bowel syndrome; especially in the overlap cases with inflammatory bowel disease.
Hasan Zaidi received his medical degree at the University of Calgary, followed by an Internal Medicine residency program and Gastroenterology fellowship at the University of Ottawa, Canada he currently practices Gastroenterology, Hepatology and therapeutic endoscopy in Oshawa, Ontario (Oshawa Clinic Group) with privileges at Lakeridge Health and Durham Regional Cancer Center. He provides evidence based care to a broad range of digestive diseases with a particular focus on colon cancer screening, endoscopic removal of early stage GI malignancy and inflammatory bowel disease. Additionally, He has a high degree of proficiency with advanced endoscopic procedures, including ERCP, luminal stenting and capsule endoscopy.
He has delivered dozens of continuing medical education lectures to physicians, pharmacists and nursing groups, and has served on advisory boards for numerous pharmaceutical companies and currently sits on Lakeridge Health Endoscopy Steering committee.
His academic and leaderships pursuits include past Chief Gastroenterology resident, past president of the Canadian Association of Interns and Residents, board member of Canadian Medical Association and member of Royal College Regional Advisory committee. He is a member of several professional organizations, including the Ontario and Canadian Association of Gastroenterology, and is actively involved in clinical research trials.
Ehab Abd-El-Atty is graduated and has a master degree of Internal Medicine from Faculty of Medicine, Alexandria University, Egypt. He has a Master degree of Medical Sciences from Faculty of Medicine, Catholic University, Leuven, Belgium. He has completed his PhD at the age of 35 years from Faculty of Medicine, Menoufia University, Egypt. He is professor of Internal Medicine, Hepatology and Gastroenterology, Faculty of Medicine, Menoufia University, Egypt. He has published more than 30 papers in reputed journals and has been serving as a reviewer of Menoufia Medical Journal (MMJ). He is a member of AASLD (American Association for the Study of the Liver Diseases), ESGE (European Society of Gastrointestinal Endoscopy), EASL (European Association for the Study of the Liver) and IASL International Association for the Study of the Liver). He is President of Egyptian gastro-hepatic Association (EGHA). He is Charring in many MS and MD theses as principle Investigator or supervisor and in discussion committee of many Theses.
Laszlo Czako is currently a clinical professor for the 1st Department of Medicine, University of Szeged. He is board certified in internal medicine, gastroenterology and diabetology and holds a health economist degree. He is extensively trained in all aspects of gastroenterology in several leading endoscopic centers (Madrid, Amsterdam, Barcelona, Hamburg, Tokyo, Vienna). He received his Ph.D. degree in 1999 and DSc degree in 2014. He is the council member of the Hungarian Society of Gastroenterology and European Group of Endoscopic Utrasonography and chairman of the Hungarian Endosonography Club. He is a member of the editorial boards and an associate editor-in-chief of several gastrointestinal international journals. He wrote more than 100 full papers (independent citations: 952, Hirsch index: 22)in peer-reviewed international journals and 12 book chapters.
He involves in lecturing on gastrointestinal diseases and training the fellows on various endoscopic procedures.
Hosny Salama is full professor of Cairo University, Faculty of medicine. He was graduated from School of Medicine, Cairo University in 1977. He established the first liver centre at Cairo University and appointed as a director for it on 1991. He also established the Egyptian Society of Stem Cell Society for Research and Therapy on 2006 & study of NASH and its complication on 2013 and appointed as a president for the society on 2006. He is the director for Jefferson-Cairo University Affiliated Ultrasound Diagnostic and research Center (JUREI) since 2001. He is the Secretary General of the International Stem Cell Study Group since 2007. He supervised 68 MS thesis and 28 MD thesis. He published 65 scientific research articles in National and International medical journal. He got the award of Science Development and Innovation in 1992 from the Egyptian Academy of Scientific Research & Cairo University Award of Distinction and Appreciation in 2010.
Mohamed Kamal El-Din Aly Fahmy Shaker is a Head of Tropical Medicine Department Faculty of Medicine Ain Shams University and Director of HCC Unit at Ain Shams University Hospitals. He is now President Elect of the African Association for the Study of Liver Diseases (AFASLD) and serves as Vice President of the Egyptian Society of Liver Cancer as well as President of the Committee of Treatment of Viral Hepatitis at Cairo branch Health Insurance Organization. Until 2012, he coordinated the Supreme Committee of the Liver in the Health Insurance Organization.
Dr. Shaker is a member of the American Association for the study of Liver Diseases (AASLD), member of the National Committee for the Control of Viral Hepatitis and member of the Honorary Editorial Board of Journal of Hepatocellular Carcinoma. He is also one of the founders of the Arabic Society for the Study of Liver Diseases (ASSLD). He is often invited to give lectures on HCC in African region at the meetings of the following distinguished societies: Libyan Society for Gastroenterology (2010), Syrian Society for Gastroenterology (2010), AASLD in San Francisco (2011), AASLD in Boston (2012), APASL in Istanbul (2015) and many more.
After graduation from Chulalongkorn University in 1976, Dr. Mahachai undertook post graduate training in internal medicine and gastroenterology at the University of Alberta, Canada and Postdoctoral Fellowship in clinical pharmacology at the University of California, San Francisco. She served as a faculty member in the Division of Gastroenterology, University of Alberta from 1985 to 1990. In 1990 she joined Chulalongkorn University where she has been actively involved in teaching, research and patient care. She served as a Chief of the Division of Gastroenterology for two terms (2004 – 2008) consecutively.
She serves on the editorial board of Helicobacterand FNM. She now serves as the President, Gastroenterology Association of Thailand and a member of publication committee, scientific committee and WDHD 2015 steering committee of the WGO and a council member, APAGE. In addition, she is a corresponding fellow in Asia for the European Helicobacter Study Group and a member of a Healthy Stomach Initiative group.
Gastric disorders including GERD, functional dyspepsia, H. pylori, UGI bleeding, mechanisms and risk factors of gastric cancer. She is also a co-investigator of many collaborative studies on H. pylori and gastric cancer risk in Asia.
Alireza Haghighi, MD, DPhil is a clinician scientist. He graduated from University of Oxford and is currently based at the Department of Genetics of Harvard Medical School and Brigham and Women’s Hospital
clinical and genetic investigation of inherited diseases, using state of the art technologies such as high throughput genotyping and next generation sequencing. He is also working on translating basic research discoveries into better diagnostics and improved management strategies.
Head, Chair of Gastroenterology and Dept of Digestive Tract Diseases , Medical University of Łódź, Poland
90-92 postdoc in Section of Gastroenterology, University of California, Davis, USA, 92-93:Research scholar in Section of Gastroenterology, Wayne State University, Detroit, Michigan, USA.
· International Association of Pancreatology – Council Member
· American Gastroenterological Association Fellow
· Polish Pancreatic Club Vice President
2007-2008: EPC President, host of the Joint Meeting of the EPC Meeting in Lodz, 25-28.06.2008
Editor: Gastroenterology Review; Editorial Board member:European Gastroent Hepatol Rev , Gastroenterologia Praktyczna, Gastroenterologia Polska, Numerous Ph.D. students, Gastroenterology fellows,developing and running basic and clinical gastroenterology research programs and research grants. More than 150 original publications on pancreatic function and imaging in chronic pancreatitis, the late outcome of acute pancreatitis and pancreatic cancer, molecular studies in pancreatic ductal adenocarcinoma, tyrosine kinases and growth factors in G.I carcinogenesis, and quality of life in chronic pancreatitis.
Molecular abnormalities in pancreatic adenocarcinoma, Early detection of pancreatic cancer-molecular markers, Differentiation of solid pancreatic tumours, Endocrine pancreatic function in chronic pancreatitis and pancreatic cancer, Adipokines in acute pancreatitis and pancreatic cancer, Quality of life, TEMPS, type A behavior in chronic pancreatitis, Genetic issues in Achalasia.
Delgado graduated from Medicine at Central University of Venezuela, followed by residence in Internal Medicine and Gastroenterology in the same University. Sheget a Master degree on Research in Liver Disease from Barcelona University (Spain) and for two years she did a training in the Hemodynamic Laboratory of Clinic Hospital in Barcelona (Spain). She is a member of Venezuelan Society of Gastroenterology and The European Association of Study of the Liver. From 2012 to 2014 was a president of the Hepatology Section of the Venezuelan Society of Gastroenterology. Her publications include areas as Portal Hypertension, vascular liver disease and viral hepatitis. Currently, she formerly served as a specialist in hepatology in the La Floresta Institute and the Felix Boada Clinic in Caracas.
Lenys Gonzalez-Valles, MD, is the Venezuelan Pediatric Gastroenterology & Nutrition of is a physician belonging to the staff of SOVENIA (Venezuelan Society of Autistic Children). She specializes in the diagnosis and treatment of GI pathology in autistic children and development delays. She has been involved in researching in collaboration with others colleagues investigates the clinical, endoscopical, histological findings of gastrointestinal mucosa of these patients, and the diagnosis of infections and immune system disorders. She is active involved in the different national and international conferences, dedicated to education, research and support for autistic children families with gastrointestinal disease.
Gastrointestinal Pathology in Autism Spectrum Disorders, The histological findings of gastrointestinal mucosa in ASD children, Diagnosis of infections and immune system disorders in ASD children.
Kewei Wang received MD degree in 1984 and got a PhD degreein 1991. His expertise has been involving in the field of medical science to study the pathogenesis of human diseases, especially mechanisms of liver disease using cellular and molecular biology techniques. Hepatic apoptosis is a pivotal step in liver diseases. Ubiquitous apoptosisis implicated in a variety of pathological conditions such as liver dysfunction, fibrosis/cirrhosis, andtumorigenesis.Dysregulation of the hepatic apoptosis leads to a common road with different entrances. Therefore, disparate strategies will be carried out:(i) to decrease apoptosis or to amplify antiapoptotic role during liver injury and repair; (ii) to promote apoptosis of hepatic stellate cells; (iii)to inhibit antiapoptotic ability in malignant cells. A series of publications were about apoptotic signaling pathways in hepatocytes, such as NFκb-survivin, C/EBPs-iNOS, Foxa2-cIAP1, and so on. These projects had successfully clarified some regulatory mechanisms of hepatic apoptosis. By examining these mechanisms through which components of the apoptotic machinery contribute to pathogenic processes, the understanding for liver injury-repair response is expanded. Hepatoprotective strategy can be designed via utilization of pro-/anti-apoptotic modalities in future. The long term goal is to identify therapeutic targets for the treatment of liver disease.
Pathogenesis of human diseases, Mechanisms of liver disease using cellular and molecular biology techniques
Mohamed Bouattour followed his medical study in the Faculty of Medicine de Sfax (Tunisia) and received his medical degree (MD) in 2005. From 2007, he became board certified in Gastroenterology and Hepatology. As first, he followed her residency in the departments of medicines in Hospitals of Sfax and Tunis (Tunisia). Then, he continued and completed her fellowship in France. He joined the departments of Hepatology, Gastroenterology, and Oncology of the Beaujon Hospital (France). He worked and participated as a medical coordinator of several phase I-III clinical trials and worked in Clinical cancers researches.
He is currently a Practitioner Physician in the department of Hepatology and a Consultant Physician in the department of Oncology; in Beaujon Hospital in France.
His areas of interest include liver diseases, liver cancers, digestive cancers, translational research and clinical trials.
He is member of several national and international societies such as the American Association for the Study of Liver Diseases (AASLD), the European Association for the Study of the Liver (EASL), the American Society of Clinical Oncology (ASCO) and the International Liver Cancer Association (ILCA).
Liver diseases, liver cancers, digestive cancers, translational research and clinical trials.
University of South Carolina School of Medicine
Akiyoshi Kinoshita was born in Tokyo in 1973. He graduated from the Faculty of Medicine, Department of Medicine at the Jikei University School of Medicine in 1998. He worked as a medical intern and resident in Jikei University Hospital, Fuji City General Hospital, and Social Insurance Sakuragaoka General Hospital. Currently, he is working as an Assistant professor and Chief of the hospital ward in the Division of Gastroenterology/Department of Internal Medicine, the Jikei University Daisan Hospital. He obtained his doctorate in medicine in 2010 and is currently a councilor of the Japanese Society of Gastroenterology, Kanto Division.
To date, he published research papers in twelve international peer review journals and reviewed nine international peer review journals. Moreover, currently, he is working as an Editorial Board member of the International Journal of Statistics in Medical Research, JSM Gastroenterology and Hepatology, Journal of Translational Medicine & Epidemiology, World Research Journal of Palliative Care & Medicine, Journal of Tumor, Journal of Gastroenterology, Pancreatology & Liver Disorders and JSM Biomarker.
Diagnosis and treatment of Gastrointestinal cancer including hepatocellular cancer, Inflammatory reaction in cancer patients, Cancer in elderly patients and Post progression survival in cancer patients